Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia A
Completed · Phase 3
Conditions studied: Hemophilia A
In brief
The primary objective of the study is to evaluate the long-term safety of recombinant human Factor VIII Fc fusion protein (rFVIIIFc) in participants with hemophilia A. The secondary objective of the study is to evaluate the efficacy of rFVIIIFc in the prevention and treatment of bleeding episodes in participants with hemophilia A.
Key facts
- Study ID
- NCT01454739
- Run by
- Bioverativ Therapeutics Inc.
- People needed
- 240
- Starts
- 2011-12-01
- Expected to finish
- 2017-10-01
- Last updated by the study team
- 2020-12-19
Who can join
Age: any. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Research Site — San Diego, California, United States
- Research Site — Washington D.C., District of Columbia, United States
- Research Site — Indianapolis, Indiana, United States
- Research Site — Iowa City, Iowa, United States
- Research Site — New Orleans, Louisiana, United States
- Research Site — Boston, Massachusetts, United States
- Research Site — East Lansing, Michigan, United States
- Research Site — St Louis, Missouri, United States
- Research Site — Las Vegas, Nevada, United States
- Research Site — Chapel Hill, North Carolina, United States
- Research Site — Cincinnati, Ohio, United States
- Research Site — Portland, Oregon, United States
- Research Site — Philadelphia, Pennsylvania, United States
- Research Site — Philadelphia, Pennsylvania, United States
- Research Site — Pittsburgh, Pennsylvania, United States
- Research Site — Houston, Texas, United States
- Research Site — Salt Lake City, Utah, United States
- Research Site — Seattle, Washington, United States
- Research Site — Camperdown, New South Wales, Australia
- Research Site — South Brisbane, Queensland, Australia
- Research Site — Adelaide, South Australia, Australia
- Research Site — Melbourne, Victoria, Australia
- Research site — Melbourne, Victoria, Australia
- Research Site — Murdoch, Western Australia, Australia
- Research Site — Sacramento, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.